Request Deal Involvement

Omega Funds, Atlas Venture, Lightspeed Venture Partners, BVF Partners, and Cormorant Asset Management led a $177m Series A round in Antares Therapeutics.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Precision AQ

pr advisors

Precision AQ

or

Principals

THE INVUS GROUP LLC

bidder

THE INVUS GROUP LLC

LIGHTSPEED VENTURE PARTNERS

bidder

LIGHTSPEED VENTURE PARTNERS

ABINGWORTH MANAGEMENT

bidder

ABINGWORTH MANAGEMENT

CORMORANT ASSET MANAGEMENT

bidder

CORMORANT ASSET MANAGEMENT

ATLAS VENTURE LP

bidder

ATLAS VENTURE LP

VIDA VENTURES

bidder

VIDA VENTURES

ANTARES THERAPEUTICS

target

ANTARES THERAPEUTICS

BVF PARTNERS

bidder

BVF PARTNERS

OMEGA FUNDS

bidder

OMEGA FUNDS

VINYANSHU VENTURES

bidder

VINYANSHU VENTURES

TENMILE

bidder

TENMILE

WILLETT ADVISORS

bidder

WILLETT ADVISORS

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - Omega Funds, Atlas Venture, Lightspeed Venture Partners, BVF Partners, and Cormorant Asset Management led a $177m Series A round in Antares Therapeutics.